| Literature DB >> 26009689 |
Jianhua Zhu1, Mingxuan Wang1, Wei Wen1, Rongmin Yu2.
Abstract
Catharanthus roseus produces a wide range of terpenoid indole alkaloids (TIA). Many of them, such as vinblastine and vincristine, have significant bioactivity. They are valuable chemotherapy drugs used in combination with other drugs to treat lymphoma and leukemia. The TIA biosynthetic pathway has been investigated for many years, for scientific interest and for their potential in manufacturing applications, to fulfill the market demand. In this review, the progress and perspective of C. roseus TIA biosynthesis and its regulating enzymes are described. In addition, the culture condition, hormones, signaling molecules, precursor feeding on the accumulation of TIA, and gene expression are also evaluated and discussed.Entities:
Keywords: Biosynthesis pathway; enzymes; gene expression; regulation; terpenoid indole alkaloids; vinblastine
Year: 2015 PMID: 26009689 PMCID: PMC4441158 DOI: 10.4103/0973-7847.156323
Source DB: PubMed Journal: Pharmacogn Rev ISSN: 0973-6581
Figure 1Biosynthesis of Catharanthus TIAs. Solid arrows indicate confirmed enzymatic conversions, whereas, the broken arrows indicate unknown enzymatic conversions. G10H: geraniol 10-hydroxylase; TDC: Tryptophan decarboxylase; STR: strictosidine synthase; SGD: Strictosidine β-D-glucosidase; T16H: 16-hydroxylase; OMT: O-methyltransferase; NMT: N-methyltransferase; D4H: Desacetoxyvindoline 4-hydroxylase; DAT: Deacetylvindoline-4-O-acetyltransferase; AVLBS: Anhydrovinblastine synthase